Proprietary algorithms use NGS to detect multiple fetal genetic abnormalities from non-invasive samples Dec 08, 2015, 08:00 ET from Maverix…
Dr. Min-Jeong Kim
Dr. Min-Jeong Kim is broadly trained biologist, and he has considerable experience with the practice of microarray and next-generation sequencing (NGS) analysis using human, plant, animal and microbial materials for academic or commercial settings. He received his Ph.D. from Seoul National University in Korea and worked at GreenGene Biotech., where he managed high throughput automatic instruments for genome and transcriptome analysis. From 2010, he joined the Dr. Gang lab at Institute of Biological Chemistry in Washington State University, and had been working on plant tissue-specific gene expression. After that, he worked at Ohio University for a while as the director of genomics facility then, moved back to Korea to work at Eone-Diagnomics Genome Center as the R&D director. There, he provided non-invasive prenatal test (NIPT) and BRCA1/2 test, and he designed a germline cancer panel for 29 genes and developed blood collection tube for cell-free DNA extraction. He also worked on developing a liquid biopsy method to detect somatic DNA variants in the blood of the cancer patients. In 2017, he came back to US to join Diagnomics, and he has been working on developing clinical assay pipelines for the SNP microarray- and NGS-based platforms.